Edit |   |
---|---|
Antigenic Specificity | Mitogen-Activated Protein Kinase 14 Phospho-Tyr323 (MAPK14 pY323) |
Clone | polyclonal |
Host Species | Rabbit |
Reactive Species | human |
Isotype | n/a |
Format | peptide affinity purified |
Size | 80 µl, 400 µl, |
Concentration | n/a |
Applications | ELISA, DB |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | This product is currently in development. The lead time for this product may be several months. Please contact us at info@abbexa.com for an updated lead time before purchasing this product. This product is currently in development. The lead time for this product may be several months. Please contact us at info@abbexa.com for an updated lead time before purchasing this product. MAPK14 is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase is activated by various environmental stresses and proinflammatory cytokines. The activation requires its phosphorylation by MAP kinase kinases (MKKs), or its autophosphorylation triggered by the interaction of MAP3K7IP1/TAB1 protein with this kinase. The substrates of this kinase include transcription regulator ATF2, MEF2C, and MAX, cell cycle regulator CDC25B, and tumor suppressor p53, which suggest the roles of this kinase in stress related transcription and cell cycle regulation, as well as in genotoxic stress response. |
Immunogen | KLH-conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding Y323 of human MAPK14. |
Other Names | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A, EXIP, PRKM14, PRKM15, RK, p38, p38ALPHA, Mitogen-activated protein kinase 14, Cytokine suppressive inflammatory drug-binding protein, MAP kinase MXI2, MAX-interacting protein 2, Mitogen-activated protein kinase p38 alpha, Stress-activated protein kinase 2a, CSAID-binding protein, MAP kinase p38 alpha, MAPK14, MAPK14, MAPK14 , MAPK14 , CSBP, CSBP, CSBP , CSBP , CSBP1, CSBP1, CSBP1 , CSBP1 , CSBP2, CSBP2, CSBP2 , CSBP2 , CSPB1, CSPB1, CSPB1 , CSPB1 , MXI2, MXI2, MXI2 , MXI2 , SAPK2A, SAPK2A, SAPK2A , SAPK2A , EXIP, EXIP, EXIP , EXIP , PRKM14, PRKM14, PRKM14 , PRKM14 , PRKM15, PRKM15, PRKM15 , PRKM15 , RK, RK, RK , RK , p38, p38, p38 , p38 , p38ALPHA, p38ALPHA, p38ALPHA , p38ALPHA , Mitogen-activated protein kinase 14, Mitogen-activated protein kinase 14, Mitogen-activated protein kinase 14 , Mitogen-activated protein kinase 14 , Cytokine suppressive inflammatory drug-binding protein, Cytokine suppressive inflammatory drug-bi |
Gene, Accession # | UniProt: Q16539 |
Catalog # | abx031985 |
Price | please inquire |
Order / More Info | Mitogen-Activated Protein Kinase 14 Phospho-Tyr323 (MAPK14 pY323) Antibody from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950